ADVERTISEMENT

http://www.hartfordbusiness.com

Day and Zindrick enter Aeromics' board of directors

9/7/2018
Mark Day and Thomas Zindrick joined the board of directors at Aeromics, a Branford-based clinical-stage pharmaceutical company focused on controlling brain swelling in stroke survivors.